Search Results 461-470 of 18756 for Neutrophil

1. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/mm^3;; Platelet count 100,000/mm^3;; Total bilirubin ≤ 1.5 upper limit of normal (ULN), or if total bilirubin is > 1.5 ...

2. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

   An absolute neutrophil count of < 1000 cells/µL during Screening. Known or suspected current (< 90 days) illicit drug use. Note: marijuana use is allowed ...

3. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm3; Platelet count ≥ 75,000/mm3; Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x ULN; SGOT (AST) ≤ 2 x ULN; Albumin ≥ 3 g ...

4. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study - Mayo Clinic

   PRE-REGISTRATION: Absolute Neutrophil Count (ANC) >= 1,200/mm^3. PRE-REGISTRATION: Platelet count >= 100,000/mm^3. PRE-REGISTRATION: Hemoglobin >= 8 g/dL. PRE ...

5. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Absolute neutrophil count (ANC) <1,000/μL (1.0 X 109/L); Platelet count <50,000/μL (50 X 109/L); Serum aspartate aminotransferase (AST)/serum glutamic ...

6. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Hemoglobin > 9.0 g/dL or ≥ 5.6 mmol/L without transfusion or (EPO) ...

7. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

   Neutrophil count ≥ 0.5 × 109/L;; Hemoglobin ≥ 8 g/dL unless lower values are attributable to CLL. Adequate renal, hepatic, cardiac and pulmonary function ...

8. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,500/mm3; Platelet count ≥ 100,000/mm3; Hemoglobin ≥ 10 g/dL; Creatinine ≤ 1.5 times the upper limit of normal with ...

9. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

   absolute neutrophil count ≥ 1.5 x 109/L; platelet count ≥ 100 x 109/L; Renal function, as follows: Serum creatinine ≤ 1.5 x the ULN or calculated ...

10. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelets (PLT) ≥100,000/mm^3;; Hemoglobin (HgB) ≥ 8.0g/dL;; Total bilirubin ≤ 1.5 x ULN;; Aspartate ...